Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P28
Within normal range
vs 3Y Ago
-0.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -19.16% |
| Q2 2025 | -3.15% |
| Q1 2025 | 51.19% |
| Q4 2024 | -0.03% |
| Q3 2024 | -36.97% |
| Q2 2024 | 19.04% |
| Q1 2024 | 41.40% |
| Q4 2023 | -24.08% |
| Q3 2023 | -35.32% |
| Q2 2023 | 105.21% |
| Q1 2023 | 1.63% |
| Q4 2022 | 17.47% |
| Q3 2022 | 25.06% |
| Q2 2022 | -37.96% |
| Q1 2022 | 24.45% |
| Q4 2021 | 23.58% |
| Q3 2021 | -25.59% |
| Q2 2021 | -4.40% |
| Q1 2021 | 181.18% |
| Q4 2020 | 3.00% |
| Q3 2020 | -30.99% |
| Q2 2020 | 113.50% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | -100.00% |
| Q2 2018 | 0.00% |